William J. Harrington

ORCID: 0000-0003-2366-0020 · 7 papers in corpus
article 1997
·doi:10.1002/(sici)1096-8652(199702)54:2<149::aid-ajh9>3.3.co;2-n

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem-cell disorder in which blood cells lack complement inhibiting membrane proteins, and become susceptible to complement-mediated injury, leading to chronic intravascular hemolysi…

review 1997
·doi:10.1002/(sici)1096-8652(199702)54:2<149::aid-ajh9>3.0.co;2-x

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem-cell disorder in which blood cells lack complement inhibiting membrane proteins, and become susceptible to complement-mediated injury, leading to chronic intravascular hemolysi…

article 1991
AIDS research and human retroviruses ·doi:10.1089/aid.1991.7.1031

Tropical spastic paraparesis or HTLV-I-associated myelopathy is a progressive spastic disorder associated with the human T-lymphotropic virus type I. Some cases have responded to prednisone. Danazol is an attenuated androgen with minimal vi…

article 1989
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fasebj.3.2.2914627

Danazol, an attenuated androgen, is useful in endometriosis, idiopathic thrombocytopenic purpura (ITP), and autoimmune hemolytic anemia (AIHA). However, its mechanism of action is unknown. We investigated the possibility that danazol affect…

article 1989
·doi:10.7326/0003-4819-111-9-723

STUDY OBJECTIVE: To assess the long-term benefit and side effects of danazol therapy, and to delineate factors influencing the responses in patients with autoimmune thrombocytopenia. DESIGN: Before and after trial. SETTING: Referral-based h…

article 1989
·doi:10.1097/00000441-198910000-00002

Danazol, an attenuated androgen, has been used successfully at its conventional dose (400-800 mg/day) in the treatment of idiopathic thrombocytopenic purpura (ITP). To minimize side effects, the authors tried a very low dose (50 mg/day) reg…

article 1985
·doi:10.7326/0003-4819-102-3-298

We evaluated the use of danazol in 15 patients with autoimmune hemolytic anemia of the warm antibody type. Danazol, 600 to 800 mg/d, was added to previous regimens or given initially in conjunction with high-dose prednisone treatment. Twelv…